Pyrrolopyridinone derivatives as TTX-S blockers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9187475
APP PUB NO 20150094306A1
SERIAL NO

14394532

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pyrrolopyridinone derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RAQUALIA PHARMA INC1-21-19 MEIEKI MINAMI NAKAMURA-KU NAGOYA-SHI AICHI 4500003

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kawamura, Kiyoshi Aichi, JP 87 1257
Morita, Mikio Aichi, JP 35 265
Yamagishi, Tatsuya Aichi, JP 26 216

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00